VP-16 IN ADVANCED SQUAMOUS-CELL AND ADENOCARCINOMA OF LUNG

被引：0
|
作者：
MCMAHON, RT [1 ]
INGLE, JN [1 ]
RUBIN, J [1 ]
KVOLS, LK [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55901
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1978年 / 19卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：396 / 396
页数：1
相关论文
共 50 条
  • [41] VINDESINE IN THE TREATMENT OF SQUAMOUS-CELL CARCINOMA, ADENOCARCINOMA, AND LARGE CELL-CARCINOMA OF THE LUNG
    OSTERLIND, K
    HORBOV, S
    DOMBERNOWSKY, P
    RORTH, M
    HANSEN, HH
    CANCER TREATMENT REPORTS, 1982, 66 (02): : 305 - 309
  • [42] ADENOCARCINOMA AND SQUAMOUS-CELL CARCINOMA IN THE SAME LOBE OF THE LUNG - A CASE-REPORT
    KITAMURA, K
    MITSUDOMI, T
    ISHIDA, T
    KANEKO, S
    SUGIMACHI, K
    RESPIRATION, 1991, 58 (3-4) : 226 - 228
  • [43] PD-L1 expression in squamous-cell carcinoma and adenocarcinoma of the lung
    Janzic, Urska
    Kern, Izidor
    Janzic, Andrej
    Cavka, Luka
    Cufer, Tanja
    RADIOLOGY AND ONCOLOGY, 2017, 51 (03) : 357 - 362
  • [44] RESPONSE RATE AND TOXICITY OF ETOPOSIDE (VP-16) IN SQUAMOUS CARCINOMA OF THE LUNG - REPORT FROM THE LUNG-CANCER-TREATMENT-STUDY-GROUP
    ANDERSON, G
    PAYNE, H
    SEMINARS IN ONCOLOGY, 1985, 12 (01) : 21 - 22
  • [45] VP-16, CYCLOPHOSPHAMIDE, ADRIAMYCIN AND CIS-PLATINUM (V-CAP-I) IN PATIENTS WITH METASTATIC ADENOCARCINOMA OF THE LUNG
    EAGAN, RT
    CREAGAN, ET
    INGLE, JN
    RUBIN, J
    FRYTAK, S
    KVOLS, LK
    FLEMING, TR
    TUMORI, 1979, 65 (01) : 105 - 109
  • [46] MONOCLONAL-ANTIBODIES REACTIVE WITH HUMAN-LUNG ADENOCARCINOMA AND SQUAMOUS-CELL CARCINOMA OF LUNG
    CHAN, JC
    HONG, JX
    ZHANG, HZ
    SHIH, DR
    HU, LF
    YU, XS
    HYBRIDOMA, 1986, 5 (01): : 61 - 61
  • [47] ETOPOSIDE AND HIGH-DOSE CISPLATIN IN GOOD-RISK PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA AND ADENOCARCINOMA OF THE LUNG
    ARDIZZONI, A
    CANOBBIO, L
    PRONZATO, P
    RUBAGOTTI, A
    DEPALMA, M
    BARACCO, F
    SERRANO, J
    SERRANO, S
    FARAVELLI, B
    NOSENZO, M
    FELLETTI, R
    ROSSO, R
    CANCER TREATMENT REPORTS, 1986, 70 (07): : 891 - 892
  • [48] BIOAVAILABILITY AND PHARMACOKINETICS OF ETOPOSIDE (VP-16)
    SMYTH, RD
    PFEFFER, M
    SCALZO, A
    COMIS, RL
    SEMINARS IN ONCOLOGY, 1985, 12 (01) : 48 - 51
  • [49] ETOPOSIDE (VP-16) AND CISPLATIN - AN EFFECTIVE TREATMENT FOR RELAPSE IN SMALL-CELL LUNG-CANCER
    EVANS, WK
    OSOBA, D
    FELD, R
    SHEPHERD, FA
    BAZOS, MJ
    DEBOER, G
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (01) : 65 - 71
  • [50] XENOGRAFT MODELS FOR TESTING VP-16 ANALOGS AGAINST VP-16 RESISTANT AND SENSITIVE HUMAN-COLON TUMOR-CELL LINES
    BASLER, GA
    SCHURIG, JE
    CROSSWELL, AR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 496 - 496
12345